4.7 Article

A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae

期刊

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
卷 60, 期 7, 页码 4159-4169

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/AAC.00365-16

关键词

-

资金

  1. European Union
  2. EFPIA
  3. Geriatric Research Education and Clinical Center (VISN 10)
  4. HHS \ National Institutes of Health (NIH) [R01AI072219, R01AI063517]
  5. MINECO \ Instituto de Salud Carlos III (ISCIII) [REIPI RD12/0015]
  6. MINECO \ Instituto de Salud Carlos III (ISCIII) (FIS) [PI10/02021]

向作者/读者索取更多资源

The spread of extended-spectrum-beta-lactamase (ESBL)-producing Enterobacteriaceae (ESBL-E) is leading to increased carbapenem consumption. Alternatives to carbapenems need to be investigated. We investigated whether beta-lactam/beta-lactamase inhibitor (BLBLI) combinations are as effective as carbapenems in the treatment of bloodstream infections (BSI) due to ESBL-E. A multinational, retrospective cohort study was performed. Patients with monomicrobial BSI due to ESBL-E were studied; specific criteria were applied for inclusion of patients in the empirical-therapy (ET) cohort (ETC; 365 patients), targeted-therapy (TT) cohort (TTC; 601 patients), and global cohort (GC; 627 patients). The main outcome variables were cure/improvement rate at day 14 and all-cause 30-day mortality. Multivariate analysis, propensity scores (PS), and sensitivity analyses were used to control for confounding. The cure/improvement rates with BLBLIs and carbapenems were 80.0% and 78.9% in the ETC and 90.2% and 85.5% in the TTC, respectively. The 30-day mortality rates were 17.6% and 20% in the ETC and 9.8% and 13.9% in the TTC, respectively. The adjusted odds ratio (OR) (95% confidence interval [CI]) values for cure/improvement rate with ET with BLBLIs were 1.37 (0.69 to 2.76); for TT, they were 1.61 (0.58 to 4.86). Regarding 30-day mortality, the adjusted OR (95% CI) values were 0.55 (0.25 to 1.18) for ET and 0.59 (0.19 to 1.71) for TT. The results were consistent in all subgroups studied, in a stratified analysis according to quartiles of PS, in PS-matched cases, and in the GC. BLBLIs, if active in vitro, appear to be as effective as carbapenems for ET and TT of BSI due to ESLB-E regardless of the source and specific species. These data may help to avoid the overuse of carbapenems. (This study has been registered at ClinicalTrials.gov under registration no. NCT01764490.)

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Letter Infectious Diseases

Rapid emergence of ceftazidime-avibactam resistance among carbapenem-resistant Enterobacterales in a tertiary-care hospital in Taiwan

Jia-Arng Lee, Shin-Hei Du, Tai-fen Lee, Yu-Shan Huang, Chun-Hsing Liao, Yu-Tsung Huang, Po-Ren Hsueh

JOURNAL OF INFECTION (2023)

Article Infectious Diseases

An early return-to-work program for COVID-19 close contacts in healthcare during the Omicron wave in Japan

Hiroyuki Naruse, Yohei Doi, Mitsunaga Iwata, Kiyohito Ishikawa

Summary: During the COVID-19 pandemic, Japan's early return-to-work (RTW) program for healthcare workers (HCWs) who have been in close contact with COVID-19 cases was found to be a reasonable strategy. HCWs eligible for the program had received the third dose of a COVID-19 mRNA vaccine, tested negative for COVID-19 before each work shift, and were difficult to replace. Out of 256 HCWs identified as close contacts, 37 secondary cases were detected, and 141 HCWs (55%) participated in the early RTW program, with no reported infection clusters.

JOURNAL OF INFECTION AND CHEMOTHERAPY (2023)

Review Pharmacology & Pharmacy

Clinical efficacy of renal dosing adjustments of ceftazidime-avibactam in patients affected by carbapenem-resistant Gram-negative infections: A systematic review and meta-analysis of observational studies

Milo Gatti, Giacomo Fornaro, Pierluigi Viale, Federico Pea, Maddalena Giannella

Summary: The aim of this study was to assess the clinical efficacy of ceftazidime-avibactam in managing carbapenem-resistant Gram-negative infections in renal patients receiving recommended dosing adjustments. The study found that renal dosing adjustments of ceftazidime-avibactam may be associated with a higher risk of mortality in patients affected by carbapenem-resistant Gram-negative infections.

BRITISH JOURNAL OF CLINICAL PHARMACOLOGY (2023)

Article Immunology

Epidemiology, Clinical Features, and Antimicrobial Resistance of Invasive Escherichia Coli Disease in Patients Admitted in Tertiary Care Hospitals

Joachim Doua, Jeroen Geurtsen, Jesus Rodriguez-Bano, Oliver A. Cornely, Oscar Go, Aina Gomila-Grange, Andrew Kirby, Peter Hermans, Andrea Gori, Valentina Zuccaro, Stefan Gravenstein, Marc Bonten, Jan Poolman, Michal Sarnecki

Summary: This multinational study describes the clinical profile of patients with invasive Escherichia coli disease (IED) in tertiary care hospitals. Most patients with IED were adults aged >= 60 years, and the urinary tract was the most common source of infection. Systemic inflammatory response syndrome (SIRS) was identified in 77.4% of patients, and the case-fatality rate was 20.0%. A proposed clinical case definition showed a 96.1% agreement with physician's diagnoses.

OPEN FORUM INFECTIOUS DISEASES (2023)

Article Microbiology

High Incidence of Candidemia in Critically Ill COVID-19 Patients Supported by Veno-Venous Extracorporeal Membrane Oxygenation: A Retrospective Study

Francesco Alessandri, Giancarlo Ceccarelli, Giuseppe Migliara, Valentina Baccolini, Alessandro Russo, Carolina Marzuillo, Mariateresa Ceparano, Giovanni Giordano, Pierfrancesco Tozzi, Gioacchini Galardo, Giammarco Raponi, Claudio Mastroianni, Mario Venditti, Francesco Pugliese, Gabriella d'Ettorre

Summary: This study analyzed the incidence of bloodstream infections (BSI) due to Candida in COVID-19 patients supported with ECMO, and found that the incidence of candidemia was significantly higher in the ECMO group compared to the control group. This result was confirmed by survival analysis and multivariable analyses.

JOURNAL OF FUNGI (2023)

Article Infectious Diseases

Specialized palliative care for hospitalized patients with SARS-CoV-2 infection: an analysis of the LEOSS registry

Kirsten Schmidt-Hellerau, Claudia Raichle, Maria Ruethrich, Joerg J. Vehreschild, Julia Lanznaster, Susana M. Nunes de Miranda, Claudia Bausewein, Maria J. G. T. Vehreschild, Carolin E. M. Koll, Steffen Simon, Kerstin Hellwig, Bjoern-Erik O. Jensen, Norma Jung

Summary: This study aimed to describe the characteristics and types of specialized palliative care (SPC) provided to SARS-CoV-2 infected patients. The study found that patients receiving SPC were older and had more comorbidities, but 59% had a life expectancy of more than 1 year. The main symptoms were dyspnea, delirium, and excessive tiredness. Most patients receiving SPC died during the hospital stay, and SPC mainly focused on symptom control and family psychological support, with a higher emphasis on allowing personal contacts with friends and relatives.

INFECTION (2023)

Article Critical Care Medicine

Epidemiology and outcomes of hospital-acquired bloodstream infections in intensive care unit patients: the EUROBACT-2 international cohort study

Alexis Tabah, Niccolo Buetti, Quentin Staiquly, Stephane Ruckly, Murat Akova, Abdullah Tarik Aslan, Marc Leone, Andrew Conway Morris, Matteo Bassetti, Kostoula Arvaniti, Jeffrey Lipman, Ricard Ferrer, Haibo Qiu, Jose-Artur Paiva, Pedro Povoa, Liesbet De Bus, Jan De Waele, Farid Zand, Mohan Gurjar, Adel Alsisi, Khalid Abidi, Hendrik Bracht, Yoshiro Hayashi, Kyeongman Jeon, Muhammed Elhadi, Francois Barbier, Jean-Francois Timsit

Summary: This study investigated hospital-acquired bloodstream infections (HA-BSI) in 2600 adult patients from 333 ICUs in 52 countries. HA-BSI were frequently caused by Gram-negative, carbapenem-resistant, and difficult-to-treat pathogens. Antimicrobial resistance led to delays in adequate antimicrobial therapy, resulting in high mortality rates.

INTENSIVE CARE MEDICINE (2023)

Article Infectious Diseases

Duration of antibiotic treatment and timing of oral switching for bloodstream infections: a survey on the practices of infectious diseases and intensive care physicians

Burcu Isler, Abdullah Tarik Aslan, Burhan Sami Benli, David L. Paterson, Nick Daneman, Robert Fowler, Murat Akova

Summary: This study investigated the current practice of antibiotic treatment duration and timing of IV to oral switching for common bacteraemic conditions among Turkish infectious disease and ICU physicians. The results showed that the most commonly recommended duration of antibiotic treatment for bacteraemia was 14 days, followed by 10 and 7 days. Most physicians recommended switching to oral antibiotics after 7 days of IV treatment. Prolonged treatment durations may be due to a presumption that resistant bacterial infections require longer therapy.

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS (2023)

Article Medicine, General & Internal

Case report: Analysis of phage therapy failure in a patient with a Pseudomonas aeruginosa prosthetic vascular graft infection

Lucia Blasco, Inmaculada Lopez-Hernandez, Miguel Rodriguez-Fernandez, Javier Perez-Florido, Carlos S. Casimiro-Soriguer, Sarah Djebara, Maya Merabishvili, Jean-Paul Pirnay, Jesus Rodriguez-Bano, Maria Tomas, Luis Eduardo Lopez Cortes

Summary: This article describes a case study of a patient with a multidrug-resistant prosthetic vascular graft infection caused by Pseudomonas aeruginosa, which was successfully treated with a combination of phages (PT07, 14/01, and PNM) and ceftazidime-avibactam (CZA). After phage therapy, a new infection with a wild-type strain of P. aeruginosa occurred, but this strain was susceptible to β-lactams and quinolones. Microbiology and whole genome sequencing techniques were used to analyze the clinical strains. The clinical isolates before and after phage therapy showed a clonal relationship with important genomic changes that may have contributed to resistance to this therapy. Phenotypic studies revealed a decrease in the Minimum Inhibitory Concentration (MIC) to β-lactams and quinolones, as well as an increase in biofilm production and phage-resistant mutants in the clinical isolate of P. aeruginosa after phage therapy.

FRONTIERS IN MEDICINE (2023)

Article Infectious Diseases

Genetic Characterization of Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates in a Tertiary Hospital in Greece, 2018-2022

Charalampos Zarras, Theodoros Karampatakis, Styliani Pappa, Elias Iosifidis, Eleni Vagdatli, Emmanuel Roilides, Anna Papa

Summary: This study aimed to investigate the antimicrobial resistance and accessory genes, clonal relatedness, and evolutionary dynamics of CRKP isolates recovered in the ICUs of a tertiary hospital in Greece. Next-generation sequencing was performed, and various bioinformatics software were used for plasmid content identification, MLST, antimicrobial resistance gene detection, comparison of genome alignments, and identification of core genome SNPs. The results showed that the isolates belonged to eight different sequence types, with various carbapenemases and resistance genes detected. The study also revealed distinct phylogenetic branches for certain sequence types, suggesting clonal dispersion. Overall, this study provides important insights into the genetic characterization of CRKP isolates in ICUs.

ANTIBIOTICS-BASEL (2023)

Editorial Material Infectious Diseases

Rapid Diagnostic Test Value and Implementation in Antimicrobial Stewardship Across Low-to-Middle and High-Income Countries: A Mixed-Methods Review

Luke S. P. Moore, Maria Virginia Villegas, Eric Wenzler, Timothy M. Rawson, Rita O. Oladele, Yohei Doi, Anucha Apisarnthanarak

Summary: Despite variable utilization of rapid diagnostic tests (RDTs) in antimicrobial stewardship programs (ASPs) across different income countries, a value framework has been proposed to define the benefits of RDTs in ASPs, separate from per-patient benefits. Effective implementation is key to realizing the value of RDTs within ASPs, and actionable advice for choosing an RDT has been proposed by infectious disease experts from various countries. These experts also advocate for the inclusion of RDTs in the World Health Organization Model List of essential in vitro diagnostics and in the iterative development of national action plans.

INFECTIOUS DISEASES AND THERAPY (2023)

Article Medicine, General & Internal

Risk factors for infections caused by carbapenem-resistant Enterobacterales: an international matched case-control- control study (EURECA)

Salvador Perez-Galera, Jose M. Bravo-Ferrer, Maria Paniagua, Tomislav Kostyanev, Marlieke E. A. de Kraker, Jan Feifel, Jesus Sojo-Dorado, Joost Schotsman, Rafael Canton, George L. Daikos, Biljana Carevic, Gorana Dragovac, Lionel K. Tan, Lul Raka, Adriana Hristea, Pierluigi Viale, Murat Akova, Jose Maria Reguera, Lucia Valiente de Santis, Julian Torre-Cisneros, Angela Cano, Emmanuel Roilides, Lili Radulovic, Cenk Kirakli, Evelyn Shaw, Matthew E. Falagas, Vicente Pintado, Herman Goossens, Marc J. Bonten, Belen Gutierrez-Gutierrez, Jesus Rodroguez-Bano

Summary: A study found that the main risk factors for CRE infections in hospitals with high incidence included previous colonization, urinary catheter use, and exposure to broad spectrum antibiotics.

ECLINICALMEDICINE (2023)

Article Health Care Sciences & Services

EPI-Net One Health reporting guideline for antimicrobial consumption and resistance surveillance data: a Delphi approach

Nithya Babu Rajendran, Fabiana Arieti, Carla Alejandra Mena-Benitez, Liliana Galia, Maela Tebon, Julio Alvarez, Beryl Primrose Gladstone, Lucie Collineau, Giulia De Angelis, Raquel Duro, William Gaze, Siri Goepel, Souha S. Kanj, Annemarie Kaesbohrer, Direk Limmathurotsakul, Estibaliz Lopez de Abechuco, Elena Mazzolini, Nico T. Mutters, Maria Diletta Pezzani, Elisabeth Presterl, Hanna Renk, Jesus Rodriguez-Bano, Oana Sandulescu, Federico Scali, Robert Skov, Thirumalaisamy P. Velavan, Cuong Vuong, Evelina Tacconelli

Summary: Strategic and standardised approaches are crucial for analyzing and reporting surveillance data on antimicrobial resistance (AMR) and informing antibiotic policies. This paper describes a multidisciplinary initiative involving experts from the human, animal, and environmental sectors to develop proposals for structuring and reporting full-scale AMR and antimicrobial consumption/antimicrobial residue surveillance data. The recommendations from this study can support national and regional plans to reduce resistance rates and promote a One Health approach to antimicrobial policy.

LANCET REGIONAL HEALTH-EUROPE (2023)

Article Immunology

Lipid signatures of West Nile virus infection unveil alterations of sphingolipid metabolism providing novel biomarkers

Patricia Mingo-Casas, Javier Sanchez-Cespedes, Ana-Belen Blazquez, Josefina Casas, Maria Balsera-Manzanero, Laura Herrero, Ana Vazquez, Jeronimo Pachon, Manuela Aguilar-Guisado, Jose Miguel Cisneros, Juan-Carlos Saiz, Miguel A. Martin-Acebes

Summary: West Nile virus (WNV) is a neurotropic flavivirus transmitted by mosquitoes and can cause severe diseases. By studying experimentally infected mice and naturally infected patients, dynamic alterations in the lipidome were identified as metabolic fingerprints of different infection stages. The dysregulation of sphingolipid metabolism by WNV may provide new therapeutic opportunities and support the potential of certain lipids as novel peripheral biomarkers of WND progression.

EMERGING MICROBES & INFECTIONS (2023)

Article Infectious Diseases

Ophthalmologic Examination and Echocardiography Should be the Essential Components of Candidemia Bundle

Cigdem Erol, Nuran Sari, Tugba Yanik-Yalcin, Ayseguel Yesilkaya, Leyla Asena, Sirel Guer-Guengoer, Oezlem Kurt-Azap

Summary: This study investigated the incidence, characteristics, and mortality of candidemia and compared the data with previous results. Candidemia has a high incidence and is associated with end-organ involvement, prolonged hospitalization, increased mortality, and higher healthcare costs. Candida albicans is the most common pathogen, while mortality rates are higher in Candida glabrata and Candida krusei infections.

INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY (2023)

暂无数据